Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.
Press releases published on March 31, 2025
Greenheart Gold Announces Trading on the OTCQB Venture Market in the United States
GlobeNewswire
·
March 31, 2025
LONGUEUIL, Quebec, March 31, 2025 (GLOBE NEWSWIRE) -- Greenheart Gold Inc. (TSXV: GHRT; OTCQB: GHRTF) (the “Company” or “Greenheart Gold”) is pleased to announce that its common shares commenced trading today on the OTCQB Venture Market (“OTCQB”) under the …
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
GlobeNewswire
·
March 31, 2025
SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago, …
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
GlobeNewswire
·
March 31, 2025
CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida …
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
GlobeNewswire
·
March 31, 2025
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung cancer (“NSCLC”) Apollomics to receive …
Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 31, 2025
WEST CHESTER, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced …
Awilco Drilling PLC: Notice of Extraordinary General Meeting
GlobeNewswire
·
March 31, 2025
An extraordinary General Meeting of Awilco Drilling PLC will be held on Wednesday 16 April 2025 at 10:00 (UK time), at the Company’s registered office of Suite 1, 7th Floor, 50 Broadway, London, SW1H 0BL, UK. The notice including agenda for the General …
Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 31, 2025
NORCROSS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December …
Trump Media to Debut on New York Stock Exchange Texas
GlobeNewswire
·
March 31, 2025
DJT Stock Will Be First Listing on New Texas Exchange SARASOTA, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq: DJT) ("TMTG" or the "Company"), operator of the social media platform Truth Social, the streaming …
Veritex Holdings, Inc. Announces Extension of Stock Buyback Program
GlobeNewswire
·
March 31, 2025
DALLAS, March 31, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or "the Company”), the parent holding company for Veritex Community Bank, today announced that its Board of Directors (the "Board") authorized the extension of the …
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 31, 2025
-- Randomized 87 patients to date in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED) -- -- Continuing enrollment into 2Q25; currently targeting topline data in 3Q25 -- -- Raised $10.75 million in private placement financing …
electroCore Extends VA Contract for Five Years
GlobeNewswire
·
March 31, 2025
ROCKAWAY, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that electroCore has received a new Federal Supply Schedule (FSS) contract, with an …
Emergent BioSolutions Announces Stock Repurchase Program
GlobeNewswire
·
March 31, 2025
GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the company’s common stock on or before March 27, 2026. “As …
Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company’s Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal…
GlobeNewswire
·
March 31, 2025
ROCKVILLE, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that a …
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
GlobeNewswire
·
March 31, 2025
WILMETTE, Ill., March 31, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced fourth quarter and …
Nasdaq Champions Smart Regulatory Reform to Strengthen the World’s Leading Capital Markets and Drive American Economic Growth
GlobeNewswire
·
March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Nasdaq today released a comprehensive set of policy recommendations in a paper titled “Advancing the U.S. Public Markets: Unlocking Capital Formation for a Stronger American Economy.” The paper draws insights …
Biora Therapeutics Successfully Completes Restructuring Process
GlobeNewswire
·
March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Biora Therapeutics, a biotech company developing the first swallowable autoinjector, today announced the successful completion of its court-supervised restructuring. Through the restructuring process, Biora …
Clip Money Inc. Reports 2024 Year End Results
GlobeNewswire
·
March 31, 2025
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP; OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the …
Luckin Coffee Files 2024 Annual Report on Form 20-F
GlobeNewswire
·
March 31, 2025
BEIJING, March 31, 2025 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “2024 Annual Report”) with the …
Norden Crown Announces Name Change to Domestic Metals Corp.
GlobeNewswire
·
March 31, 2025
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Norden Crown Metals Corporation (“Norden Crown” or the “Company”) (TSXV:NOCR, OTC:NOCRF, Frankfurt:03E) announces it has changed its name to Domestic Metals Corp. (TSXV:DMCU) in accordance …
Australian Oilseeds Announces Second Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
March 31, 2025
COOTAMUNDRA, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT) today announced financial results for its second quarter fiscal 2025 ended December 31, 2024. …